# Buyang Huanwu Decoction With Wuling Powder for Acute Ischemic Stroke

> **NCT07687043** · NA · COMPLETED · sponsor: **Liaoning University of Traditional Chinese Medicine** · enrollment: 102 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **PROCEDURE:** Standard Western Medical Treatment
- **OTHER:** Serum Sample Collection for Metabolomics Only
- **DRUG:** Buyang Huanwu Decoction Combined With Wuling Powder
- **PROCEDURE:** Standard Western Medical Treatment

## Key facts

- **NCT ID:** NCT07687043
- **Lead sponsor:** Liaoning University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-20
- **Primary completion:** 2025-04-20
- **Final completion:** 2025-06-30
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687043, "Buyang Huanwu Decoction With Wuling Powder for Acute Ischemic Stroke". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*